Review Article
The Usefulness of Xuefu Zhuyu Tang for Patients with Angina Pectoris: A Meta-Analysis and Systematic Review
Table 6
The effect of XFZYT for SAP and UAP group, outcome = RAS.
| | Study ID |
Treatment duration | Response rate, %; (response/) |
Therapeutic gain, % |
NNT |
RR | | Experimental | Control |
| | Lv, 2009 [22] | 4 weeks | 93.8 (30/32) | 76.7 (23/30) | 17.1 | 5.8 | 1.22 | | Wang et al., 2000 [18] | 4 weeks | 73.5 (25/34) | 70.4 (19/27) | 3.1 | 32.3 | 1.04 | | Du et al., 2013 [29] | 6 weeks | 79.3 (73/92) | 64.0 (32/50) | 15.3 | 6.5 | 1.24 | | Wang and Jing, 2007 [19] | 4 weeks | 87.1 (27/31) | 60.0 (18/30) | 27.1 | 3.7 | 1.45 | | Li and Zhang, 2011 [27] | 4 weeks | 90.0 (54/60) | 66.7 (40/60) | 23.3 | 4.3 | 1.35 | | Liu et al., 2007 [25] | 8 weeks | 86.0 (37/43) | 76.7 (33/43) | 9.4 | 10.6 | 1.12 | | Zhang, 2012 [17] | 4 weeks | 94.0 (47/50) | 70.0 (35/50) | 24.0 | 4.2 | 1.34 | | Li, 2009 [30] | 4 weeks | 95.0 (38/40) | 70.0 (28/40) | 25.0 | 4.0 | 1.36 | | Pooled RR | — | 86.6 (331/382) | 69.1 (228/330) | 17.5 | 5.7 | 1.25 |
|
|
NNT: number needed to treat; RR: risk ratio.
|
